Orchestra BioMed Holdings, Inc. - Ordinary Shares (OBIO)

OBIO stock results show that Orchestra BioMed Hldgs missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

OBIO stock results show that Orchestra BioMed Hldgs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

OBIO stock results show that Orchestra BioMed Hldgs beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.

The company got approval from the FDA to go ahead with a pivotal study for a hypertension therapy.

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 200 points on Tuesday. The Dow traded down 0.69% to 34,384.29 while the NASDAQ fell 0.82% to 13,597.78. The S&P 500 also fell, dropping, 0.63% to 4,425.66.

U.S. stocks traded lower on Tuesday. Here are some big stocks recording gains in today’s session.

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi.

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.

The stock bounced back from hitting an all-time low the day before.

Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private investment positions.

U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session.